These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 2156430

  • 21. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP, Nicosia RF.
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [Abstract] [Full Text] [Related]

  • 22. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
    Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S.
    Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365
    [Abstract] [Full Text] [Related]

  • 23. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 24. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG, Hughes KS.
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [Abstract] [Full Text] [Related]

  • 25. [Loss of fragile histidine triad expression and metastasis in breast cancer].
    Zhao P, Li XY, Chen LZ.
    Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
    [Abstract] [Full Text] [Related]

  • 26. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
    Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Löhrs U.
    Anticancer Res; 1999 Jun; 19(5B):4257-64. PubMed ID: 10628384
    [Abstract] [Full Text] [Related]

  • 27. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 28. Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha5(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors.
    Nakano S, Iyama K, Ogawa M, Yoshioka H, Sado Y, Oohashi T, Ninomiya Y.
    Lab Invest; 1999 Mar; 79(3):281-92. PubMed ID: 10092064
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA.
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [Abstract] [Full Text] [Related]

  • 30. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB, Lee MW, Zarbo RJ, Crissman JD.
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [Abstract] [Full Text] [Related]

  • 31. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L, Sarcević B, Malenica B, Novak D.
    Neoplasma; 1993 Nov; 40(2):69-74. PubMed ID: 8394515
    [Abstract] [Full Text] [Related]

  • 32. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [Abstract] [Full Text] [Related]

  • 33. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.
    Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A.
    Am J Pathol; 1993 Apr; 142(4):987-93. PubMed ID: 7682767
    [Abstract] [Full Text] [Related]

  • 34. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
    Esposito NN, Dabbs DJ, Bhargava R.
    Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
    [Abstract] [Full Text] [Related]

  • 35. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
    Gottlieb C, Raju U, Greenwald KA.
    Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
    [Abstract] [Full Text] [Related]

  • 36. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease.
    Sauer T, Pedersen MK, Ebeltoft K, Naess O.
    Cytopathology; 2005 Aug; 16(4):193-8. PubMed ID: 16048505
    [Abstract] [Full Text] [Related]

  • 37. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue.
    Dillon DC, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T, Asch HL.
    Am J Clin Pathol; 2002 Sep; 118(3):451-8. PubMed ID: 12219788
    [Abstract] [Full Text] [Related]

  • 38. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, Collan Y.
    Cancer Res; 1998 Feb 01; 58(3):432-6. PubMed ID: 9458085
    [Abstract] [Full Text] [Related]

  • 39. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 01; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 40. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency?
    Meyer S, Brumm C, Stegner HE, Sinnecker GH.
    Exp Clin Endocrinol; 1994 Jan 01; 102(4):334-40. PubMed ID: 7529185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.